The Journal of Immunology · 2002 · 107 citations · 44 references
Life SciencesImmunologyPharmacologyImmunopharmacologyInflammationMolecular PharmacologyAsthma PharmacotherapyOxidative StressOxidative Stress In InflammationOxidative Stress MechanismsReactive Oxygen SpeciesRedox SignalingAllergic Airway InflammationAp-1 Transcriptional ControlAsthma ModelsAsthma PathophysiologyAsthmatic Mucus HypersecretionNf-κb SignalingRedox Regulation Of Transcription FactorsRedox-sensitive Transcription Factors
An oxidant/antioxidant imbalance is seen in the lungs of patients with asthma. This oxidative stress in asthmatic airways may lead to activation of redox-sensitive transcription factors, NF-kappaB and AP-1. We examined the effect of the small molecule inhibitor of redox-regulated NF-kappaB and AP-1 transcription, MOL 294 on airway inflammation and airway hyperreactivity (AHR) in a mouse model of asthma. MOL 294 is a potent nonpeptide inhibitor of NF-kappaB and AP-1 based upon a beta-strand template that binds to and inhibits the cellular redox protein thioredoxin. BALB/c mice after i.p. OVA sensitization (day 0) were challenged with intranasal OVA on days 14, 25, 26, and 27. MOL 294, administered intranasal on days 25-27, blocked the airway inflammatory response to OVA assessed 24 h after the last OVA challenge on day 28. MOL 294 reduced eosinophil, IL-13, and eotaxin levels in bronchoalveolar lavage fluid and airway tissue eosinophilia and mucus hypersecretion. MOL 294 also decreased AHR in vivo to methacholine. These results support redox-regulated transcription as a therapeutic target in asthma and demonstrate that selective inhibitors can reduce allergic airway inflammation and AHR.
44
Patrick A. Baeuerle, David Baltimore · Cell · 1996 · 3K citations · Full text
Redox Regulation of Fos and Jun DNA-Binding Activity in Vitro
Cory Abate, Lekha Patel, Frank J. Rauscher et al. · Science · 1990 · 1.6K citations